Best Practices for Lowering the Risk of Cardiovascular Disease in Diabetes

Author:

Triplitt Curtis,Alvarez Carlos A.

Abstract

In Brief Cardiovascular disease (CVD) is a common complication of diabetes; nearly 80% of all people with diabetes will die from macrovascular complications. Dyslipidemia, hypertension, hypercoagulability, poor glycemic control,smoking, obesity, and lack of physical activity are just some of the multiple risk factors responsible for the increased risk of CVD in diabetes. A multi-pronged approach to address these risk factors is imperative. Although nonpharmacological therapy is the cornerstone of treatment, some pharmacological treatments are almost always warranted. These may include statins for dyslipidemia and their pleiotropic effects, tight blood pressure control (especially with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers), antiplatelet therapy, and appropriately tight glycemic control based on comorbidities. Evidence has shown that this approach can reduce the risk of CVD in diabetes but that these strategies continue to be underutilized.

Publisher

American Diabetes Association

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference95 articles.

1. NIH/NIDDK Statistics Clearinghouse:National diabetes statistics: death among people with diabetes, 2006 [article online]. Available from: www.diabetes.niddk.nih.gov/dm/pubs/statistics/index.htm#deathsAccessed 22 July 2008

2. Goldstein LB,Adams R, Becker K, Furberg CD, Gorelick PB, Hademenos G, Hill M, Howard G,Howard VJ, Jacobs B, Levine SR, Mosca L, Sacco RL, Sherman DJ, Wolf PA,delZoppo G: Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke 32:280–299, 2001

3. Haffner SM Lehto S, Ronnemaa T, Pyorala K, Laasko M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339: 229-234,1998

4. Goede P, Vedel P,Larson N, Jensen GVH, Parving H-H, Pedersen O: Multifactorial intervention in cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348:383–393, 2003

5. Goede P,Lund-Anderson H, Parving H-H, Pederson O: Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 358:580–591, 2008

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3